Oxytocin inhibits NADPH oxidase and P38 MAPK in cisplatin-induced nephrotoxicity

被引:65
|
作者
Rashed, Laila A. [2 ]
Hashem, Reem M. [1 ]
Soliman, Hala M. [3 ]
机构
[1] Beni Sueif Univ, Fac Pharm, Dept Biochem, Bani Suwayf 62514, Egypt
[2] Cairo Univ, Fac Med, Dept Biochem, Cairo, Egypt
[3] Zagazig Univ, Fac Med, Dept Histol, Zagazig, Egypt
关键词
Cisplatin; Oxytocin; Nephrotoxicity; NADPH oxidase; P38; MAPK; ACUTE-RENAL-FAILURE; TUBULAR EPITHELIAL-CELLS; OXIDATIVE STRESS; NITRIC-OXIDE; SUPEROXIDE-DISMUTASE; DEPENDENT MECHANISM; RATS; KINASE; APOPTOSIS; TOXICITY;
D O I
10.1016/j.biopha.2011.07.001
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Oxidative stress significantly contributes to cisplatin (CP)-associated cytotoxicity, and use of antioxidants could counteract such cytotoxic effects of CP. The major biochemical pathway for reactive oxygen species (ROS) formation proceeds through O(2)(-) production, which is generated by NADPH oxidase, such oxidative stress can activate p38 MAPK to intensify the cytotoxic effect of CP. We mainly aimed to study the protective effect of oxytocin (OT) on CP-induced nephrotoxicity whereas; it was previously shown to have anti-inflammatory effects in different inflammation models. Administration of OT significantly decreased the gene expression of both NADPH oxidase and P38 MAPK, nitric oxide (NO), myloperoxidase (MPO), and TBARS, furthermore it increased the renal tissue levels of antioxidants; reduced glutathione (GSH), and superoxide dismutase (SOD). Histologically, OT reduced the monocellular infiltration as well as the tubular damage in CP-induced nephrotoxicity. In conclusion OT has a powerful antioxidant effect that can alleviate the CP-induced nephrotoxicity through inhibition of NADPH oxidase and P38 MAPK resulting in improvement of kidney functions. (C) 2011 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:474 / 480
页数:7
相关论文
共 50 条
  • [41] Role of the p38 MAPK pathway in cisplatin-based therapy
    Losa, JH
    Cobo, CP
    Viniegra, JG
    Lobo, VJSA
    Cajal, SRY
    Sánchez-Prieto, R
    ONCOGENE, 2003, 22 (26) : 3998 - 4006
  • [42] Berberine-photodynamic therapy sensitizes melanoma cells to cisplatin-induced apoptosis through ROS-mediated P38 MAPK pathways
    Wang, Xiaotong
    Gong, Qianyi
    Song, Changfeng
    Fang, Jiaping
    Yang, Yun
    Liang, Xin
    Huang, Xuan
    Liu, Jianwen
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2021, 418
  • [43] Suppression of NADPH oxidase 4 inhibits PM2.5-induced cardiac fibrosis through ROS-P38 MAPK pathway
    Wu, Meiqiong
    Xing, Qisong
    Duan, Huiling
    Qin, Guohua
    Sang, Nan
    SCIENCE OF THE TOTAL ENVIRONMENT, 2022, 837
  • [44] Tetrathiomolybdate mediates cisplatin-induced p38 signaling and EGFR degradation and enhances response to cisplatin therapy in gynecologic cancers
    Kim, Kyu Kwang
    Han, Alex
    Yano, Naohiro
    Ribeiro, Jennifer R.
    Lokich, Elizabeth
    Singh, Rakesh K.
    Moore, Richard G.
    SCIENTIFIC REPORTS, 2015, 5
  • [45] Tetrathiomolybdate mediates cisplatin-induced p38 signaling and EGFR degradation and enhances response to cisplatin therapy in gynecologic cancers
    Kyu Kwang Kim
    Alex Han
    Naohiro Yano
    Jennifer R. Ribeiro
    Elizabeth Lokich
    Rakesh K. Singh
    Richard G. Moore
    Scientific Reports, 5
  • [46] NADPH and NAC synergistically inhibits chronic ocular hypertension-induced neurodegeneration and neuroinflammation through regulating p38/MAPK pathway and peroxidation
    Yu, Naiji
    Wu, Xingdi
    Zhang, Chengshou
    Qin, Qiyu
    Gu, Yuxiang
    Ke, Weishaer
    Liu, Xin
    Zhang, Qi
    Liu, Zhenjie
    Chen, Min
    Wang, Kaijun
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 175
  • [47] Calcium induced mitochondrial biogenesis and p38 MAPK
    Wright, DC
    Geiger, P
    Jones, T
    Han, DH
    Garcia-Roves, P
    Holloszy, J
    FASEB JOURNAL, 2005, 19 (04): : A115 - A115
  • [48] p38 MAPK in MDS
    Ganan-Gomez, Irene
    Bohannan, Zachary S.
    Garcia-Manero, Guillermo
    AGING-US, 2015, 7 (06): : 346 - 347
  • [49] LZAP Inhibits p38 MAPK (p38) Phosphorylation and Activity by Facilitating p38 Association with the Wild-Type p53 Induced Phosphatase 1 (WIP1)
    An, Hanbing
    Lu, Xinyuan
    Liu, Dan
    Yarbrough, Wendell G.
    PLOS ONE, 2011, 6 (01):
  • [50] Targeting MAPK p38 path inhibits chemoresistance in colon cancer
    Paillas, S.
    Boissiere, F.
    Bibeau, F.
    Denouel, A.
    Mollevi, C.
    Causse, A.
    Denis, V
    Vezzio, N.
    Marzi, L.
    Cortijo, C.
    Arsa, Ait, I
    Askari, N.
    Engelberg, D.
    Martineau, P.
    Del Rio, M.
    Gongora, C.
    BULLETIN DU CANCER, 2010, 97 : S47 - S48